Novel sialidase inhibitors 11 having an α-acylaminoamido group at the C-4 position of Neu5Ac2en 1 against human parainfluenza virus type 1 (hPIV-1) were synthesized using one-pot isocyanide-based fourcomponent condensation, and their inhibitory activities against hPIV-1 sialidase were studied. Compound 11b showed inhibitory activity (IC 50 =5.1 mm) against hPIV-1 sialidase. The degree of inhibition of 11b was much weaker than that of 1 (IC 50 =0.3 mm).
Human parainfluenza viruses (hPIVs), members of the human parainfluenza viruses (hPIVs), which are part of the Paramyxoviridae family, are important respiratory tract pathogens in infants and children. Four different types of hPIV have been identified, all of which cause a spectrum of illnesses of the upper and lower respiratory tracts of children.
1,2)
There are currently no effective vaccines or specific therapies available for controlling parainfluenza virus infections.
3) Parainfluenza virus contains 2 spike glycoproteins, hemagglutininneuraminidase (HN) glycoproteins, and fusion (F) glycoprotein, embedded in the envelope. HN proteins recognize sialic acid-containing glycolipids and glycoproteins of target cells; this recognition allows the virus to bind to target cells. Furthermore, HN proteins act as a sialidase, removing sialic acid from virus particles, and thus preventing self-aggregation and promoting efficient spread of the virus. The multifunctional role of HN in the viral life cycle makes it an attractive target for structure-based design of chemotherapeutics to treat hPIV infection. Among the diverse array of compounds related to the sialic acid family, 4) 5-acetamido-2,6-anhydro-3,5-dideoxy-d-galacto-d-glycero-non-2-enonic acid (Neu5Ac2en, 1) is known as an inhibitor of sialidases from both bacterial and viral sources, occupying an important position in modern chemistry. 5, 6) A variety of Neu5Ac2en analogs have been synthesized as competitive sialidase inhibitors. By molecular modeling techniques, von Itzstein et al. reported the design and biological evaluation of 4-deoxy-4-guanidino-Neu5Ac2en analogs (2) (zanamivir). 7) In sialic acids, C-4 near the anomeric center seems to play an important role in enzymesubstrate interactions. Neu5Ac2en derivatives with structural modifications at the C-4 position are particular candidates for the design of potent inhibitors against anti-paramyxovirus agents. Although the amino acid sequences of hPIV-1 surface glycoproteins have been described, 8, 9 ) the crystal structure model of a complex of hPIV-1 HN glycoprotein and 1 has not been undetermined. In 2004, Portner et al. reported that compounds BCX 2798 (3) and BCX 2855 (4) with modifications at C-4 and C-5 positions of 1, which were designs based on the crystal structure of the HN of Newcastle disease virus (NDV), were specific and potent inhibitors of hPIVs. 10) We demonstrated that 4-O-amidinomethyl-5, 11, 12) 4-O-thiocarbamamoylmethyl-6, [11] [12] [13] 4-O-ethyl-7, 14) and 4-O-(2-thienyl-2-propynyl) Neu5Ac2en derivatives 8 15) have potential inhibitory activities against the sialidase from hPIV-1.
Multicomponent reactions (MCRs) have become important tools in modern preparative synthetic chemistry owing to their exceptional synthetic efficiency. 16, 17) MCRs have emerged as valuable tools for the preparation of structurally diverse chemical libraries of drug-like carbohydrates.
18) Recently, we reported the synthesis of novel compounds 9 and 10 with an N-sulfonylamidino group at the C-4 position of 1, using threecomponent coupling as the key reaction, and the analysis of their inhibitory activities against hPIV-1 sialidase 19) (Fig. 1 ). For further insight into the interaction of sialidase with a substituent at C-4 of Neu5Ac2en derivatives, we herein report the synthesis of novel compounds 11 with an α-acylaminoamido group at the C-4 position of 1 using isocyanide-based four-component reaction 20) of 4-isocyano Neu5Ac2en derivative 12 as a key intermediate; we also studied their inhibitory activities against hPIV-1 sialidase (Chart 1). Ugi reactions 21) are particularly interesting as they are more versatile and diverse than other MCRs. To the best of our knowledge, there are no reports on the synthesis of Neu5Ac2en analogs with an α-acylaminoamido group 11 at the C-4 position of 1 using isocyanide-based multicomponent reactions.
Results and Discussion
Synthesis of 12 4-Isocyano Neu5Ac2en derivative 12, a key intermediate for synthesizing target compounds 11, contains an isocyanide group, which was prepared from Neu5Ac in seven steps (Chart 2). Initially, methyl ester of Neu5Ac, derived from Neu5Ac, was converted to 13 in a quantitative yield in two steps. Reaction of compound 13 with TMSOTf in AcOEt at 50°C gave 14, followed by subsequent treatment by TMSN 3 in t-BuOH, which afforded compound 15 22) in 80% yield in two steps. Reduction of an azide group of 15 with Lindlar catalyst and NEt 3 in AcOEt under H 2 atmosphere followed by the treatment with acetic formic acid anhydride gave compound 17 in 86% yield in two steps. Transformation of a formyl group to a cyanide group of 17 with CBr 4 , PPh 3 , and NEt 3 23) in CH 2 Cl 2 at −20°C successfully afforded 12 in 67% yield.
Synthesis of 11 Ugi coupling reaction was performed using the combination of 4-cyano Neu5Ac2en derivative 12, amines (1.25 eq), aldehydes (1.25 eq), and carboxylic acids (1.25 eq) in MeOH as shown in Table 1 . Under the optimized conditions, many groups of four components were smoothly coupled to afford the corresponding α-acylaminoamido compounds (18a-f) in yields ranging from 52 to 85% (entries 1-6). In entry 7, when AcOH was added as an acid (2.4 eq), the corresponding product 18g was successfully obtained in 71% yield (entry 7). In the nuclear magnetic resonance (NMR) spectra of the products, N-methyl protons of an α-acylaminoamido group at the C-4 position of 18a, 18e, and 18f appeared as two singlets, due to the partial double bond character of the nitrogen-carbonyl carbon bond.
Zemplen O-deacetylation of 18a-d with 0.1 m sodium methoxide in MeOH followed by subsequent hydrolysis with 0.1 m NaOH-MeOH (1 : 1) gave the target compounds 11a-d in yields ranging from 85% to 98% ( Table 2) .
The formation of 18 can be explained by the mechanism shown in Chart 3. The carbonyl group could be protonated by carboxylic acid, which could facilitate formation of an iminium cation A. Nucleophilic addition of isocyanide 12 to iminium intermediate B, followed by the attack with carboxylate anion, gave intermediate C, which could then be converted to final product 18.
Biological Evaluation The behavior of compounds 11a-d toward hPIV-1 sialidase was tested by a fluorometric assay using 4-methylumbelliferyl N-acetyl-α-neuraminic acid as per our previously reported method.
12) As can be seen in Table 2 , among synthesized compounds 11a-d, compound 11b showed inhibitory activity (IC 50 =5.1 mm) against hPIV-1 sialidase. However, the degree of inhibition of 11b was much weaker than that of 1 (IC 50 =0.3 mm). The reason for the lower a) Heated at 60°C for 4 h with AcOH (2.4 eq). inhibitory activity of compounds 11 is unclear in this study, but it was found that the substituent bulkiness at the C-4 alcohol of 1 might affect interaction with the cavity of the catalytic pocket in HN glycoprotein in sialidase ( Table 2 , entry 4). These studies suggest that diminished activity results from fewer favorable interactions between 11 and enzyme.
Conclusion
In conclusion, the one-pot isocyanide-based four-component condensation of 4-cyano-Neu5Ac2en derivative 12, amines, aldehydes, and carboxylic acids provided 2,3-didehydro sialic acids having an α-acylaminoamido group at the 4-O-position in MeOH in good yields. This methodology offers several advantages, including high product yield, ease of experimental procedure, and amenability to large-scale operations.
These findings should provide useful information for the development of anti-human parainfluenza virus compounds.
Experimental
All melting points are uncorrected. Optical rotations were measured with a JASCO P-1030s (Japan) digital polarimeter. IR spectra were recorded on a SHIMADZU IRPrestige-21 (Japan) spectrometer. 1 H-NMR spectra were recorded with a JEOL ECA-500 (500 MHz) (Japan) instrument.
13
C-NMR spectra were recorded with a JEOL ECA-500 (126 MHz) (Japan) instrument. Chemical shifts are expressed in ppm relative to Me 4 Si (δ= 0) in CDCl 3 and in D 2 O referenced to HOD (4.85 ppm) as internal standards. MS and high resolution (HR)-FAB-MS data were obtained using a JEOL JMS-700 (Japan) spectrometer in the positive mode with an NBA matrix. MS and HR-electrospray ionization (ESI) were measured on a JEOL JMS-T100LC (Japan) mass spectrometer. Column chromatography was performed on Silica Gel 60 (70-230 mesh, Merck). All reactions were monitored using TLC (Silica Gel 60F 254 , E. Merck, Germany) by charring after spraying 5% H 2 SO 4 in MeOH and then heating. (16 mL , 0.20 mmol), n-propylamine (16 mL, 0.19 mmol) , and AcOH (10 mL, 0.17 mmol) in MeOH (2.5 mL) in a manner similar to the preparation of 18a, to give 18b (69 mg, 79%). 
IR (neat) cm

Methyl 5-Acetylamino-2,6-anhydro-3,5-dideoxy-4-[2-(acetylbenzylamino) acetylamino]-d-glycero-d-galactonon-2-enonate (18c)
The reaction was carried out using 12 (50 mg, 0.11 mmol), formaldehyde solution (37 wt% in H 2 O) (10 mL, 0.12 mmol), benzylamine (14 mL, 0.13 mmol), and AcOH (8 mL, 0.14 mmol) in MeOH (1.0 mL) in a manner similar to the preparation of 18a, to give 18c (57 mg, 84%). 10 (1H, s), 6.48 (1H, d, J=7.9 Hz), 5.96 (1H, d, J=10.4 Acetylamino-2,6-anhydro-3,5-dideoxy-4-[2-(acetylmethylamino) butyrylamino]-d-glycero-d-galactonon-2-enonate (18f) The reaction was carried out using 12 (82 mg, 0.19 mmol), propionaldehyde (95%) (16 mL, 0.21 mmol), methylamine solution (40 wt% in H 2 O) (24 mL, 0.23 mmol), and AcOH (13 mL, 0.23 mmol) in MeOH (2.5 mL) in a manner similar to the preparation of 18a, to give 18f (57 mg, 52%). IR (neat) cm in MeOH (0.5 mL) was added n-propylamine (12 mL, 0.14 mmol) at room temperature. The reaction mixture was stirred at the same temperature for 10 min. To the reaction mixture was added AcOH (9 mL, 0.15 mmol) and a solution of compound 12 (59 mg, 0.13 mmol) in MeOH (2 mL), and the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was heated at 60°C for 4 h, and concentrated. The residue was purified by silica gel column chromatography (eluent: EtOAc-MeOH) to afford 11g (60 mg, 71%). IR (neat) cm 5 mol/L in MeOH) (24 mL, 0.12 mmol) at 0°C, and the mixture was stirred for 1 h at the same temperature. The reaction mixture was evaporated to dryness, the residue was dissolved in MeOH (1.0 mL), to the mixture was added 1 m NaOH (1.0 mL) at 0°C, and the mixture was stirred for 20 min at the same temperature. The reaction mixture was treated with Amberlite IRC-120 (H + ), the suspension was filtered, and the filtrate was evaporated in vacuo. The residue was purified by column chromatography on silica gel using CHCl 
